TNF-antibodies top biologic sales for 2008
This is a discussion on TNF-antibodies top biologic sales for 2008 within the Biotechnology News forum, part of the Industry News and Updates category; In a business report from La Merie S.L., anti-TNF antibodies were the top-selling class of biologics in ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
03-12-2009, 02:07 PM
|
||||
|
||||
TNF-antibodies top biologic sales for 2008
In a business report from La Merie S.L., anti-TNF antibodies were the top-selling class of biologics in 2008 with total sales of $16.4B. Etancercept was the top sold brand, with sales of $6.4B, while adalimumab was the anti-TNF agent with the strongest growth in 2008.
Read more... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Biologic agents for psoriasis - policy criteria | chantell.reagan | Managed Care Issues for Injectable Drugs | 2 | 05-27-2010 11:50 AM |
| Biologic agents for Rheumatoid Arthritis - policy criteria | chantell.reagan | Managed Care Issues for Injectable Drugs | 7 | 03-22-2010 11:07 AM |
| Biologic agents for ankylosing spondylitis - policy criteria | chantell.reagan | Managed Care Issues for Injectable Drugs | 0 | 02-19-2009 10:34 AM |
| Biogen's Tysabri sales disappoint Street | industry_news | Biotechnology News | 0 | 02-06-2009 01:14 PM |
| Biotech drug sales grow 12.5% in 2007 | industry_news | Biotechnology News | 0 | 06-17-2008 07:00 PM |
© 2008 DrugManagementForum™ powered by |
 |